Clinical Trial Detail

NCT ID NCT01949337
Title Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Alliance for Clinical Trials in Oncology
Indications

prostate adenocarcinoma

Therapies

Abiraterone

Prednisone

Enzalutamide

Age Groups: adult

No variant requirements are available.